|
1
|
Casimiro de Almeida J, Lou-Meda R, Olbert
M, Seifert M, Weiss G, Wiegerinck ET, Swinkels DW, Solomons NW and
Schümann K: The Growth Attainment, Hematological, Iron Status and
Inflammatory Profile of Guatemalan Juvenile End-Stage Renal Disease
Patients. PLoS One. 10:e01400622015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Naini AE, Asiabi RE, Keivandarian N and
Moeinzadeh F: Effect of omega-3 supplementation on inflammatory
parameters in patients on chronic ambulatory peritoneal dialysis.
Adv Biomed Res. 4:1672015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weng CH, Hu CC, Yen TH and Huang WH:
Association between ambient carbon monoxide and secondary
hyperparathyroidism in nondiabetic patients undergoing peritoneal
dialysis. Ther Clin Risk Manag. 11:1401–1408. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poesen R, Ramezani A, Claes K, Augustijns
P, Kuypers D, Barrows IR, Muralidharan J, Evenepoel P, Meijers B
and Raj DS: Associations of soluble CD14 and endotoxin with
mortality, cardiovascular disease, and progression of kidney
disease among patients with CKD. Clin J Am Soc Nephrol.
10:1525–1533. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Higuchi T, Abe M, Mizuno M, Yamazaki T,
Suzuki H, Moriuchi M, Oikawa O, Okawa E, Ando H and Okada K:
Association of restless legs syndrome with oxidative stress and
inflammation in patients undergoing hemodialysis. Sleep Med.
16:941–948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hashemian SJ, Rismanchi M, Esfahani EN,
Khoshvaghti A and Razi F: Effect of calcitriol supplementation and
tail suspension on serum biomarkers of bone formation in rats. J
Diabetes Metab Disord. 14:142015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaysen GA, Johansen KL, Chertow GM,
Dalrymple LS, Kornak J, Grimes B, Dwyer T, Chassy AW and Fiehn O:
Associations of Trimethylamine N-Oxide with nutritional and
inflammatory biomarkers and cardiovascular outcomes in patients new
to dialysis. J Ren Nutr. 25:351–356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie LM, Ge YY, Huang X, Zhang YQ and Li
JX: Effects of fermentable dietary fiber supplementation on
oxidative and inflammatory status in hemodialysis patients. Int J
Clin Exp Med. 8:1363–1369. 2015.PubMed/NCBI
|
|
9
|
Hassan K, Hassan S, Anwar S, Zaher A,
Edgem R and Hassan F: Predictors of left ventricular hypertrophy
and their cutoffs in peritoneal dialysis patients. Int Heart J.
56:186–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mpio I, Cleaud C, Arkouche W and Laville
M: Results of therapeutics strategy of protein-energy wasting in
chronic hemodialysis: A prospective study during 12 months. Nephrol
Ther. 11:97–103. 2015.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao H, Ye H, Sun Z, Shen X, Song Z, Wu X,
He W, Dai C and Yang J: Circulatory mitochondrial DNA is a
pro-inflammatory agent in maintenance hemodialysis patients. PLoS
One. 9:e1131792014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang WH, Yen TH, Chan MJ and Su YJ:
Environmental carbon monoxide level is associated with the level of
high-sensitivity C-reactive protein in peritoneal dialysis
patients. Medicine (Baltimore). 93:e1812014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
do Sameiro-Faria M, Kohlova M, Ribeiro S,
Rocha-Pereira P, Teixeira L, Nascimento H, Reis F, Miranda V,
Bronze-da-Rocha E, Quintanilha A, et al: Potential cardiovascular
risk protection of bilirubin in end-stage renal disease patients
under hemodialysis. Biomed Res Int. 2014:1752862014.PubMed/NCBI
|
|
14
|
Hung AM, Booker C, Ellis CD, Siew ED,
Graves AJ, Shintani A, Abumrad NN, Himmelfarb J and Ikizler TA:
Omega-3 fatty acids inhibit the up-regulation of endothelial
chemokines in maintenance hemodialysis patients. Nephrol Dial
Transplant. 30:266–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mikolasevic I, Lukenda V, Racki S, Milic
S, Sladoje-Martinovic B and Orlic L: Nonalcoholic fatty liver
disease (NAFLD)-a new factor that interplays between inflammation,
malnutrition, and atherosclerosis in elderly hemodialysis patients.
Clin Interv Aging. 9:1295–1303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Janda K, Krzanowski M, Dumnicka P,
Kuśnierz-Cabala B, Kraśniak A and Sulowicz W: Transforming growth
factor beta 1 as a risk factor for cardiovascular diseases in
end-stage renal disease patients treated with peritoneal dialysis.
Clin Lab. 60:1163–1168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ockene IS, Matthews CE, Rifai N, Ridker
PM, Reed G and Stanek E: Variability and classification accuracy of
serial high-sensitivity C-reactive protein measurements in healthy
adults. Clin Chem. 47:444–450. 2001.PubMed/NCBI
|
|
18
|
Banerjee T, Kim SJ, Astor B, Shafi T,
Coresh J and Powe NR: Vascular access type, inflammatory markers,
and mortality in incident hemodialysis patients: The Choices for
healthy outcomes in caring for End-Stage renal disease (CHOICE)
study. Am J Kidney Dis. 64:954–961. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsai MT, Hu FH, Lien TJ, Chen PJ, Huang TP
and Tarng DC: Interaction between geriatric nutritional risk index
and decoy receptor 3 predicts mortality in chronic hemodialysis
patients. Am J Nephrol. 40:191–199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Viaene L, Meijers BK, Bammens B,
Vanrenterghem Y and Evenepoel P: Serum concentrations of p-cresyl
sulfate and indoxyl sulfate, but not inflammatory markers, increase
in incident peritoneal dialysis patients in parallel with loss of
residual renal function. Perit Dial Int. 34:71–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rivara MB, Ikizler TA, Ellis CD, Mehrotra
R and Himmelfarb J: Association of plasma F2-isoprostanes and
isofurans concentrations with erythropoiesis-stimulating agent
resistance in maintenance hemodialysis patients. BMC Nephrol.
16:792015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mustafar RB, Mohd R, Miswan NA, Bain A,
Cader R, Gafor AH, Mohammad M, Shah SA, Kamaruddin NA and Kong NC:
The effects of calcitriol with calcium carbonate supplementation on
inflammatory biomarkers in chronic kidney disease patients' with
low vitamin D. Cent Eur J Immunol. 39:236–242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rivara MB, Mehrotra R, Linke L, Ruzinski
J, Ikizler TA and Himmelfarb J: A pilot randomized crossover trial
assessing the safety and short-term effects of pomegranate
supplementation in hemodialysis patients. J Ren Nutr. 25:40–49.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Vinuesa SG, Goicoechea M, Kanter J,
Puerta M, Cachofeiro V, Lahera V, Gómez-Campdera F and Luño J:
Insulin resistance, inflammatory biomarkers, and adipokines in
patients with chronic kidney disease: effects of angiotensin II
blockade. J Am Soc Nephrol. 17 12 Suppl:S206–S212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saddadi F, Alatab S, Pasha F, Ganji MR and
Soleimanian T: The effect of treatment with N-acetylcysteine on the
serum levels of C-reactive protein and interleukin-6 in patients on
hemodialysis. Saudi J Kidney Dis Transpl. 25:66–72. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bossola M, Di Stasio E, Giungi S, Rosa F
and Tazza L: Fatigue is associated with serum interleukin-6 levels
and symptoms of depression in patients on chronic hemodialysis. J
Pain Symptom Manage. 49:578–585. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Van Buren PN, Lewis JB, Dwyer JP, Greene
T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline
IG, et al: The phosphate binder ferric citrate and mineral
metabolism and inflammatory markers in maintenance dialysis
patients: Results from prespecified analyses of a randomized
clinical trial. Am J Kidney Dis. 66:479–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
As'habi A, Tabibi H, Hedayati M,
Mahdavi-Mazdeh M and Nozary-Heshmati B: Association of
malnutrition-inflammation score, dialysis-malnutrition score and
serum albumin with novel risk factors for cardiovascular diseases
in hemodialysis patients. Ren Fail. 37:113–116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cho Y, Hawley CM and Johnson DW: Clinical
causes of inflammation in peritoneal dialysis patients. Int J
Nephrol. 2014:9093732014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xing L: Effect of different dialysis
methods on cellular immunity function of maintenance haemodialysis
patients. West Indian Med J. 64:499–505. 2015.PubMed/NCBI
|
